SUCCESS STORIES
-
Consolidating Clinical Supply Chain Operations With GxP Inventory
4/18/2024
A Japan-based biotechnology company leveraged Signant SmartSignals® GxP Inventory, which improved visibility, reduced risks and costs, and optimized operations in this case study.
-
RTSM: Randomization And Cohort Management, IP Inventory Management
4/17/2024
Signant’s SmartSignals® RTSM solution helped an innovative biopharmaceutical company secure an FDA Orphan Drug designation for its cardiomyopathy drug.
-
Unified Platform Supports Rapid Implementation Of Rescue Study
1/17/2024
Explore how these integrated solutions helped an emerging biopharma to implement a plan for study build and migration with minimal disruption to sites.
-
eSource For A COVID Treatment Trial
1/17/2024
Unearth how this emerging biopharmaceutical company was able to overcome challenges to successfully facilitate a Phase 2 trial for a COVID-19 treatment in critically ill patients.
-
Emerging Biopharm Rapidly Sets Up Phase 1 Oncology Trial
1/16/2024
Uncover how an emerging biopharmaceutical company was able to expedite the initiation of a Phase 1 oncology trial for a novel treatment targeting relapsed/refractory multiple myeloma.
-
eClinical Platform Accelerates COVID-19 Treatment Trial By 2 Weeks
1/8/2024
Examine a COVID-19 treatment trial that utilized integrated EDC, eConsent, eCOA, RTSM, and TeleVisit solutions, all within a single platform, to address three critical challenges.
-
Best Practices For Changing From One eClinical Vendor To Another
10/24/2023
Switching solution providers mid-study isn't uncommon. But how can teams avoid schedule delays, interrupted operations, and errors? Learn best practices from this example by Signant Biotech.
-
Breakthrough Therapy Designation Accelerates Oncology Treatment Development
10/24/2023
Find out how this evidence-generation company's solutions and scientific expertise enabled early and successful regulatory submission for a novel oncology therapeutic.
-
Global Pharmaceutical Company Implements Remote Clinician Ratings
8/30/2023
Uncover the secret to how this pharma company was able to implement remote clinician ratings in a multinational Alzheimer’s disease.
-
RTSM Manages Clinical IP Dispensation In Schizophrenia Study
8/30/2023
Challenged by the dispensation of an investigational product (IP) across diverse patient subgroups, see what solution this pharma was able to utilize to ensure optimal distribution and minimize wastage.